JP2024545602A5 - - Google Patents
Info
- Publication number
- JP2024545602A5 JP2024545602A5 JP2024529302A JP2024529302A JP2024545602A5 JP 2024545602 A5 JP2024545602 A5 JP 2024545602A5 JP 2024529302 A JP2024529302 A JP 2024529302A JP 2024529302 A JP2024529302 A JP 2024529302A JP 2024545602 A5 JP2024545602 A5 JP 2024545602A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleotide
- double
- stranded oligonucleotide
- hsd17b13
- skeletal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163264360P | 2021-11-19 | 2021-11-19 | |
| US63/264,360 | 2021-11-19 | ||
| US202263268775P | 2022-03-02 | 2022-03-02 | |
| US63/268,775 | 2022-03-02 | ||
| US202263377482P | 2022-09-28 | 2022-09-28 | |
| US63/377,482 | 2022-09-28 | ||
| PCT/US2022/050371 WO2023091644A2 (en) | 2021-11-19 | 2022-11-18 | Hsd17b13-related double stranded oligonucleotide compositions and methods relating thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024545602A JP2024545602A (ja) | 2024-12-10 |
| JP2024545602A5 true JP2024545602A5 (cg-RX-API-DMAC10.html) | 2025-11-27 |
Family
ID=86397758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529302A Pending JP2024545602A (ja) | 2021-11-19 | 2022-11-18 | Hsd17b13関連二本鎖オリゴヌクレオチド組成物及びそれに関連する方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240384273A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4433596A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024545602A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023091644A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202106378VA (en) | 2018-12-21 | 2021-07-29 | Ionis Pharmaceuticals Inc | Modulators of hsd17b13 expression |
| MX2022014606A (es) * | 2020-05-22 | 2023-03-08 | Wave Life Sciences Ltd | Composiciones de oligonucleótidos bicatenarios y métodos relacionados con las mismas. |
| US20240352464A1 (en) * | 2023-03-07 | 2024-10-24 | Aligos Therapeutics, Inc. | Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof |
| WO2024255748A1 (zh) * | 2023-06-16 | 2024-12-19 | 施能康医药科技(苏州)有限公司 | 靶向17-β-羟基类固醇脱氢酶13的核酸及其用途 |
| WO2025184661A1 (en) * | 2024-03-01 | 2025-09-04 | Wave Life Sciences Ltd. | Double stranded oligonucleotide compositions and methods relating thereto |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3094728B1 (en) * | 2014-01-16 | 2022-03-09 | Wave Life Sciences Ltd. | Chiral design |
| CA3049980A1 (en) * | 2017-01-23 | 2018-07-26 | Regeneron Pharmaceuticals, Inc. | Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof |
| US11603532B2 (en) * | 2017-06-02 | 2023-03-14 | Wave Life Sciences Ltd. | Oligonucleotide compositions and methods of use thereof |
| JP7348185B2 (ja) * | 2017-12-21 | 2023-09-20 | アルニラム ファーマスーティカルズ インコーポレイテッド | キラル富化二本鎖rna剤 |
| MY207352A (en) * | 2018-03-21 | 2025-02-21 | Regeneron Pharma | 17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof |
| US12534728B2 (en) * | 2018-09-19 | 2026-01-27 | Arrowhead Pharmaceuticals, Inc. | RNAi agents for inhibiting expression of 17beta-HSD type 13 (HSD17B13), compositions thereof, and methods of use |
| SG11202106378VA (en) * | 2018-12-21 | 2021-07-29 | Ionis Pharmaceuticals Inc | Modulators of hsd17b13 expression |
-
2022
- 2022-11-18 JP JP2024529302A patent/JP2024545602A/ja active Pending
- 2022-11-18 EP EP22896516.6A patent/EP4433596A4/en active Pending
- 2022-11-18 WO PCT/US2022/050371 patent/WO2023091644A2/en not_active Ceased
-
2024
- 2024-05-17 US US18/667,824 patent/US20240384273A1/en active Pending